Physicians use Hemopro 1, which is only marketed outside the U.S., and Hemopro 1.5 to create a new path for blood flow in the ...

Competition in the fast-growing pulsed field ablation (PFA) market has intensified with the arrival of Johnson & Johnson’s ...

Boston Scientific announced the acquisition in January, but the review timeline dragged on after the Federal Trade Commission ...

The alliance positions GE Healthcare to distribute Radnet software designed to help mammography centers view images, ...

With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

The genetic testing firm will also close its therapeutics arm. CEO Anne Wojcicki said the cuts are necessary to “focus on the ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Donald Trump’s election victory comes weeks after the FDA named a new leader for the medical device center and as the ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...